Can Novartis Convince Insurers a $2.1 Million Gene Therapy Is a Great Deal?
May 26, 2019 at 18:31 PM EDT
Getting end payers on board with a seven-figure price for Zolgensma won't be easy.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.